GLP-1 Tracker Levello is a health tracking app for individuals on GLP-1 medication, providing injection logging and weight progress visualization on iOS and Android.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual medication tracking by providing a centralized, visual history of injections and side effects.
For Individuals undergoing GLP-1 treatment (semaglutide or tirzepatide) who need to track medication schedules, side effects, and weight progress.
What does it look like?
Key features
Logs injection date, time, dosage, and site with history tracking
Visualizes estimated medication levels over time using generalized pharmacokinetic models
Monitors weight progress with automated BMI calculation and trend charts
How much does it cost?
Advanced pharmacokinetic features are gated behind an auto-renewable subscription, which currently fails to convert due to core functional gaps.
Velocity
Maintenance developmentperformanceopaqueShow more...
GLP-1 Tracker Levello maintains a low-frequency release cadence, averaging approximately 0.08 releases per week. The latest release arrived 43 days ago, following a significant period of inactivity on the iOS platform where the last update occurred 196 days ago. Development is currently limited to minor maintenance and performance improvements, with no evidence of new features or live operations. The project remains in a maintenance state with no clear roadmap for feature expansion.
Who built it?
Tapnetic
9 apps tracked · Health & Fitness
Home Security Camera - Visory
SnapPlan - LiDAR Room Scan
Baby Monitor Saby + Cry Alarm
Dictum - Medical AI Scribe
Baby Snooze: Sleep Tracker
Hando: Co-Parenting & Custody
Eye Coach: exercises for eyes
Voxie: AI Voice CoachUser Sentiment
What do users think recently?
Recent user voice shows an upset sentiment.
How are ratings & reviews evolving?
What users say, by theme
- The inability to adjust medication dosage settings prevents users from managing their health requirements effectively
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for GLP-1 Tracker Levello
How's the Health & Fitness market?
GLP-1 Tracker Levello maintains a minimal footprint in the Health & Fitness category with a 1-star rating from a single review. The 153-day average update interval signals a lack of competitive urgency in a rapidly evolving health-tracking space.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP-1 Tracker Levello
Where is it heading?
The health-tracking market is consolidating around apps that offer high-frequency updates and deep customization. GLP-1 Tracker Levello remains exposed due to its maintenance-only cadence and failure to address fundamental user needs, which will likely result in continued low conversion and negative sentiment.
- The lack of major updates for six months suggests a stalled development cycle, which erodes user trust in a health-tracking tool.
- Critical functional gaps regarding dosage settings prevent users from managing their treatment, leading to immediate churn and negative sentiment.
The SWOT
- Pharmacokinetic estimation models provide a data-driven differentiator
- Adding dosage customization would address primary user complaints
Next best moves
Enable flexible dosage modifications because users report current settings prevent effective health management → increase user retention
+ 1 more prioritized moveThe counter-intuitive read
The app's maintenance-mode status is a greater threat than its poor rating…
Read the full takeBottom line
Enabling dosage customization would unlock the utility of the pharmacokinetic engine, which currently sits behind a paywall that users are unlikely to convert on given the reported interface friction.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated